Download PDFPDF

1402 A potent, CD8 T cell targeted IL-2 A-Kine with a broad therapeutic window induces antitumor immunity in syngeneic and humanized mouse tumor models
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address